Secondary Plasma Cell Leukemia Life Expectancy

When patients develop plasma cell leukemia after their original multiple myeloma it is secondary plasma cell leukemia.

Secondary plasma cell leukemia life expectancy.

Normal plasma cells in the bone marrow produce antibodies that fight infection. Pcl manifests when the cancerous plasma cells are seen in the bloodstream not just in the bone marrow. Secondary plasma cell leukemia occurs in 1 to 4 patients out of 100 patients who are with myeloma and it is becoming more common as the life span of myeloma patients is increasing. I had never had myeloma before it was my original diagnosis.

I was diagnosed with primary plasma cell leukemia in 2012. Plasma cell leukemia pcl is a plasma cell dyscrasia i e. Plasma cell leukemia is a rare and typically very aggressive form of blood cancer. It s often related closely to multiple myeloma and sometimes presents as a secondary form of this disease more often though it occurs all on its own which is usually known as a primary diagnosis.

Plasma cell leukemia pcl is an aggressive form of multiple myeloma characterized by high levels of abnormal plasma cells circulating in the peripheral circulating blood. A disease involving the malignant degeneration of a subtype of white blood cells called plasma cells it is the terminal stage and most aggressive form of these dyscrasias constituting 2 to 4 of all cases of plasma cell malignancies. Given that actual treatment of spcl is unsatisfactory novel therapeutic approaches are needed in order to improve outcome and quality of life in these patients. Plasma cell leukemia is more commonly seen in african americans than caucasians.